The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated safety and long term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL.
 
Jeremy S. Abramson
Consulting or Advisory Role - Celgene; Genentech/Roche; Gilead Sciences; Novartis; Seagen
Research Funding - Celgene (Inst); genentech (Inst); Millennium (Inst); Seagen (Inst)
 
Leo I. Gordon
Patents, Royalties, Other Intellectual Property - Zylem
Other Relationship - Gilead Sciences
 
Maria Lia Palomba
Consulting or Advisory Role - Celgene; Merck; Pharmacyclics
 
Matthew Alexander Lunning
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Genentech; Gilead Sciences; Juno Therapeutics; Pharmacyclics; Seagen; TG Therapeutics
 
Jon E. Arnason
Consulting or Advisory Role - Gilead Sciences; Regeneron
 
Andres Forero-Torres
Speakers' Bureau - Seagen
Research Funding - Daiichi Sankyo (Inst); Genentech (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Novartis (Inst); Oncothyreon (Inst); Pfizer (Inst); Seagen (Inst); Syndax (Inst); TRACON Pharma (Inst)
 
Michael Wang
Honoraria - AstraZeneca; Janssen; Pharmacyclics
Consulting or Advisory Role - Adienne; Asana Biosciences; AstraZeneca; Bioinvent; Celgene; Io Therapeutics; Janssen; MORE Health; Nordic Bioscience; Pharmacyclics
Research Funding - Acerta Pharma; Asana Biosciences; AstraZeneca; BeiGene; Celgene; Janssen; Juno Therapeutics; Karus Therapeutics; Kite, a Gilead company; Novartis; Oncoceutics; Oncternal Therapeutics; Pharmacyclics
Travel, Accommodations, Expenses - Celgene; Janssen; Pharmacyclics
 
David G. Maloney
Consulting or Advisory Role - Celgene; Eureka Therapeutics; Genentech/Roche; Gilead Sciences; Kite, a Gilead company; Novartis
Research Funding - Juno Therapeutics (Inst); Kite, a Gilead company (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on 2 provisional patents (Inst)
 
Alison Sehgal
Research Funding - Juno Therapeutics; Kite, a Gilead company; Merck; Prothena
 
Charalambos Andreadis
Employment - Genentech (I)
Stock and Other Ownership Interests - Roche/Genentech (I)
Consulting or Advisory Role - Astellas Pharma; Bayer; Genentech/Roche; Gilead Sciences; Kite, a Gilead company; Pharmacyclics; Seagen; Spectrum Pharmaceuticals
Research Funding - Amgen; Cellerant; GlaxoSmithKline; Karyopharm Therapeutics; Novartis
 
Enkhtsetseg Purev
Consulting or Advisory Role - Celgene
 
Scott R. Solomon
No Relationships to Disclose
 
Nilanjan Ghosh
Consulting or Advisory Role - Janssen; Juno Therapeutics; Kite, a Gilead company; Spectrum Pharmaceuticals
Speakers' Bureau - Abbvie; Celgene; Gilead Sciences; Janssen Oncology
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Janssen (Inst); Juno Therapeutics (Inst); Pharmacyclics (Inst); Seagen (Inst); TG Therapeutics (Inst)
 
Tina M. Albertson
Employment - Juno Therapeutics
Stock and Other Ownership Interests - Juno Therapeutics
Patents, Royalties, Other Intellectual Property - Juno Therapeutics
Travel, Accommodations, Expenses - Juno Therapeutics
 
Benhuai Xie
Employment - Takeda
Stock and Other Ownership Interests - Juno Therapeutics
 
Jacob Garcia
Employment - Juno Therapeutics
Stock and Other Ownership Interests - Juno Therapeutics
Patents, Royalties, Other Intellectual Property - Juno Therapeutics
Travel, Accommodations, Expenses - Juno Therapeutics
 
Tanya Siddiqi
Consulting or Advisory Role - Juno Therapeutics
Speakers' Bureau - Pharmacyclics/Janssen; Seagen
Research Funding - Acerta Pharma (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Juno Therapeutics; Kite, a Gilead company